Antibody-mediated antigen loss switches augmented immunity to antibody-mediated immunosuppression
Authors:
- Patricia E. ZerraPZPatricia E. Zerra
- Satheesh ChonatSCSatheesh Chonat
- Diyoly AyonaDADiyoly Ayona
- Cheryl L. MaierCMCheryl L. Maier
- Dominique MoraisDMDominique Morais
- Shang-Chuen WuSWShang-Chuen Wu
- Chance John LuckeyCLChance John Luckey
- Stephanie C. EisenbarthSEStephanie C. Eisenbarth
- John D. RobackJRJohn D. Roback
- 21 September 2023
- journal article
- research article
- Published by American Society of Hematology in Blood
- Vol. 142 (12) , 1082-1098
Abstract
Antibodies against fetal red blood cell (RBC) antigens can cause hemolytic disease of the fetus and newborn (HDFN). Reductions in HDFN due to anti-RhD antibodies have been achieved through use of Rh immune globulin (RhIg), a polyclonal antibody preparation that causes antibody-mediated immunosuppression (AMIS), thereby preventing maternal immune responses against fetal RBCs. Despite the success of RhIg, it is only effective against 1 alloantigen. The lack of similar interventions that mitigate immune responses toward other RBC alloantigens reflects an incomplete understanding of AMIS mechanisms. AMIS has been previously attributed to rapid antibody-mediated RBC removal, resulting in B-cell ignorance of the RBC alloantigen. However, our data demonstrate that antibody-mediated RBC removal can enhance de novo alloimmunization. In contrast, inclusion of antibodies that possess the ability to rapidly remove the target antigen in the absence of detectable RBC clearance can convert an augmented antibody response to AMIS. These results suggest that the ability of antibodies to remove target antigens from the RBC surface can trigger AMIS in situations in which enhanced immunity may otherwise occur. In doing so, these results hold promise in identifying key antibody characteristics that can drive AMIS, thereby facilitating the design of AMIS approaches toward other RBC antigens to eliminate all forms of HDFN.Keywords
This publication has 77 references indexed in Scilit:
- Alloantibodies to a paternally derived RBC KEL antigen lead to hemolytic disease of the fetus/newborn in a murine modelBlood, 2013
- Minor histocompatibility antigens on transfused leukoreduced units of red blood cells induce bone marrow transplant rejection in a mouse modelBlood, 2009
- Management of Rhesus Alloimmunization in PregnancyObstetrics & Gynecology, 2008
- Neonatal alloimmune thrombocytopeniaHaematologica, 2008
- Galectin-1, -2, and -3 Exhibit Differential Recognition of Sialylated Glycans and Blood Group AntigensJournal of Biological Chemistry, 2008
- The clearance kinetics of autologous RhD-positive erythrocytes coated ex vivo with novel recombinant and monoclonal anti-D antibodiesClinical and Experimental Immunology, 2007
- Human and murine anti-Rh monoclonal antibodies. A comparison of serological, immunochemical, cellular and functional activityRevue Française de Transfusion et Immuno-hématologie, 1988
- Characterization of a monoclonal antibody directed against mouse macrophage and lymphocyte Fc receptors.Journal of Experimental Medicine, 1979
- Dose of anti-D gamma-globulin in prevention of Rh-haemolytic disease of the newborn.BMJ, 1966
- Experimental Studies on the Prevention of Rh Haemolytic DiseaseBMJ, 1961